| Literature DB >> 35867388 |
Bethan Naunton Morgan1, Gill Windle2, Rebecca Sharp3, Carolien Lamers4.
Abstract
BACKGROUND: The prevalence of dementia is increasing, and there are many associated problems that family members face as informal carers, including emotional, physical, and financial difficulties. There are benefits for a person with dementia to live at home for as long as possible, and therefore, supporting their informal carers is crucial. The growing interest in supporting carers through internet-based interventions is evidenced by the volume of systematic reviews on this topic. It is now appropriate to systematically examine this body of work and provide an overview of the literature.Entities:
Keywords: Alzheimer disease; caregivers; carers; dementia; family; informal; internet; interventions; online; technology
Mesh:
Year: 2022 PMID: 35867388 PMCID: PMC9356334 DOI: 10.2196/36727
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Figure 1Keyword search terms and number of results for the 3 database searches.
A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2 questions, responses, and “critical” items.
| AMSTAR 2 questions | Responses | Critical domain |
| Did the research questions and inclusion criteria for the review include the components of PICOa? | Yes or no | No |
| Did the report of the review contain an explicit statement that the review methods were established before the conduct of the review, and did the report justify any significant deviations from the protocol? | Yes or partial yes or no | Yes |
| Did the review authors explain their selection of the study designs for inclusion in the review? | Yes or no | No |
| Did the review authors use a comprehensive literature search strategy? | Yes or partial yes or no | Yes |
| Did the review authors perform study selection in duplicate? | Yes or no | No |
| Did the review authors perform data extraction in duplicate? | Yes or no | No |
| Did the review authors provide a list of excluded studies and justify the exclusions? | Yes or partial yes or no | Yes |
| Did the review authors describe the included studies in adequate detail? | Yes or partial yes or no | No |
| Did the review authors use a satisfactory technique for assessing RoBb in individual studies that were included in the review? | For RCTsc—yes or partial yes or no or includes only NRSId; for NRSI—yes or partial yes or no or includes only RCTs | Yes |
| Did the review authors report on the sources of funding for the studies included in the review? | Yes or no | No |
| If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results? | For RCTs—yes or no or no meta-analysis conducted; for NRSI—yes or no or no meta-analysis conducted | Yes |
| If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? | Yes or no or no meta-analysis conducted | No |
| Did the review authors account for RoB in primary studies when interpreting or discussing the results of the review? | Yes or no | Yes |
| Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? | Yes or no | No |
| If they performed quantitative synthesis, did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? | Yes or no or no meta-analysis conducted | Yes |
| Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review? | Yes or no | No |
aPICO: population, intervention, control group, outcome.
bRoB: risk of bias.
cRCT: randomized controlled trial.
dNRSI: nonrandomized studies of intervention.
Figure 2PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) diagram of the selection process.
Depression measures used in the 21 review papers.
| Authors | Depression measures | Number of depression measures |
| Leng et al, 2020 [ | CES-Da, BDI-IIb, and PHQ-9c questions | 3 |
| Deeken et al, 2019 [ | CES-D, BDI, GDSd, and BSIe depression subscale | 4 |
| Hopwood et al, 2018 [ | CES-D and PHQ-9 | 2 |
| Boots et al, 2014 [ | CES-D | 1 |
| Egan et al, 2018 [ | CES-D and BDI-II | 2 |
| Jackson et al, 2016 [ | CES-D, BDI, and GDRSf | 3 |
| Lucero et al, 2019 [ | NRg | NR |
| Pleasant et al, 2020 [ | CES-D, BDI-II, and GDS | 3 |
| Scott et al, 2016 [ | CES-D and BDI-SFh | 2 |
| Waller et al, 2017 [ | CES-D, BDI-II, PHQ-9, GDS, and SDSi | 5 |
| Zhao et al, 2019 [ | CES-D and BDI-II | 2 |
| Etxeberria et al, 2020 [ | CES-D, BDI, PHQ, and SDS | 4 |
| Frias et al, 2020 [ | CES-D | 1 |
| Godwin et al, 2013 [ | CES-D | 1 |
| Kishita et al, 2018 [ | CES-D and BDI | 2 |
| Klimova et al, 2019 [ | CES-D | 1 |
| Parra-Vidales et al, 2017 [ | CES-D and BDI | 2 |
| Powell et al, 2008 [ | NR | NR |
| Lee, 2015 [ | CES-D | 1 |
| Thompson et al, 2007 [ | NR | NR |
| McKechnie et al, 2014 [ | CES-D | 1 |
aCES-D: Center for Epidemiologic Studies Depression Scale.
bBDI-II: Beck Depression Inventory-II.
cPHQ-9: Patient Health Questionnaire-9.
dGDS: Geriatric Depression Scale.
eBSI: Brief Symptom Inventory.
fGDRS: Geriatric Depression Rating Scale.
gNR: not reported.
hBDI-SF: Beck Depression Inventory short form.
iSDS: Zung Self-Rating Depression Scale.
Summary of intervention content, delivery, and results of the 4 most commonly measured outcomes.
| Study | Intervention content, n (%) | Intervention delivery, n (%) | Depressiona | Anxietya | Burdena | Self-efficacya | |||||||||||
|
| Educational | Psychotherapeutic | Social | Multicomponent | Telephone | DVD | Computer | Mixed |
|
|
|
| |||||
| Leng et al, 2020 [ | 9 (52.9) | 1 (5.9) | 0 (0) | 7 (41.2) | 0 (0) | 0 (0) | 14 (82.4) | 3 (17.6) | + | + | – | + | |||||
| Deeken et al, 2019 [ | 6 (18.2) | 7 (21.2) | 2 (6.1) | 18 (54.5) | 11 (33.3) | 1 (3) | 11 (33.3) | 10 (30.3) | + | NRc | + | NR | |||||
| Hopwood et al, 2018 [ | 8 (20) | 0 (0) | 2 (5) | 30 (75) | 0 (0) | 0 (0) | 39 (97.5) | 1 (2.5) | + | + | + | + | |||||
| Boots et al, 2014 [ | 3 (25) | 0 (0) | 0 (0) | 9 (75) | 0 (0) | 0 (0) | 9 (75) | 3 (25) | + | – | ? | + | |||||
| Egan et al, 2018 [ | 4 (50) | 1 (12.5) | 0 (0) | 3 (37.5) | 0 (0) | 0 (0) | 6 (75) | 2 (25) | ? | + | – | + | |||||
| Jackson et al, 2016 [ | 6 (27.3) | 3 (13.6) | 2 (9.1) | 11 (50.0) | 13 (59.1) | 0 (0) | 5 (22.7) | 4 (18.2) | ? | + | + | + | |||||
| Lucero et al, 2019 [ | 0 (0) | 0 (0) | 0 (0) | 12 (100) | 6 (50) | 1 (8.3) | 2 (16.7) | 3 (25) | ? | ? | ? | ? | |||||
| Pleasant et al, 2020 [ | 18 (94.7) | 0 (0) | 0 (0) | 1 (5.3) | 0 (0) | 0 (0) | 19 (100) | 0 (0) | + | + | ? | ? | |||||
| Scott et al, 2016 [ | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 0 (0) | 2 (50) | 2 (50) | 0 (0) | + | NR | NR | NR | |||||
| Waller et al, 2017 [ | 0 (0) | 12 (35.3) | 3 (8.8) | 19 (55.9) | 15 (44.1) | 0 (0) | 10 (29.4) | 9 (26.5) | ? | ? | ? | ? | |||||
| Zhao et al, 2019 [ | 2 (33.3) | 0 (0) | 0 (0) | 4 (66.7) | 0 (0) | 0 (0) | 4 (66.7) | 2 (33.3) | + | + | – | NR | |||||
| Etxeberria et al, 2020 [ | 4 (44.4) | 0 (0) | 0 (0) | 5 (55.6) | 0 (0) | 0 (0) | 9 (100) | 0 (0) | + | – | – | NR | |||||
| Frias et al, 2020 [ | 4 (50) | 4 (50) | 0 (0) | 0 (0) | 3 (37.5) | 0 (0) | 3 (37.5) | 2 (22.2) | ? | ? | ? | + | |||||
| Godwin et al, 2013 [ | 1 (12.5) | 0 (0) | 0 (0) | 7 (87.5) | 4 (50) | 0 (0) | 3 (37.5) | 1 (12.5) | + | + | + | + | |||||
| Kishita et al, 2018 [ | 4 (44.4) | 5 (55.6) | 0 (0) | 0 (0) | 4 (44.4) | 2 (22.2) | 2 (22.2) | 1 (11.1) | ? | + | ? | NR | |||||
| Klimova et al, 2019 [ | 4 (66.7) | 1 (16.7) | 0 (0) | 1 (16.7) | 0 (0) | 0 (0) | 6 (100) | 0 (0) | + | NR | NR | NR | |||||
| Parra-Vidales et al, 2017 [ | 5 (71.4) | 0 (0) | 0 (0) | 2 (28.6) | 0 (0) | 0 (0) | 6 (85.7) | 1 (14.3) | + | + | NR | ? | |||||
| Powell et al, 2008 [ | 0 (0) | 2 (13.3) | 0 (0) | 13 (86.7) | 2 (13.3) | 0 (0) | 11 (73.3) | 2 (13.3) | ? | ? | ? | + | |||||
| Lee, 2015 [ | 0 (0) | 0 (0) | 5 (100) | 0 (0) | 0 (0) | 1 (20.0) | 3 (60.0) | 1 (20.0) | + | NR | ? | + | |||||
| Thompson et al, 2007 [ | 0 (0) | 0 (0) | 0 (0) | 4 (100) | 2 (50) | 0 (0) | 1 (25) | 1 (25) | – | NR | NR | NR | |||||
| McKechnie et al, 2014 [ | 0 (0) | 8 (57.1) | 0 (0) | 6 (42.9) | 0 (0) | 1 (7.1) | 11 (78.6) | 2 (14.3) | ? | + | + | ? | |||||
a+ indicates an improvement, ? indicates mixed results, and – indicates no significant improvement or improvements in the control group.
bThe papers are the results from meta-analyses rather than the results from individual studies.
cNR: not reported.